38 results

• FDA’s REMS Drug Safety Program Sometimes Confusing To Patients, And A Barrier To Drug Access: Study

  January 24, 2022

  Martha Garcia

  A new study finds that many patients are confused by the FDA's REMS drug safety program, which adds extra requirements to drugs with potentially severe side effects.

• Side Effects of Rituxan for MS Treatment May Carry Increased Infection Risks: Study

  October 15, 2019

  Martha Garcia

  Some newer MS drugs increase the risk of infection, according to the findings of a new study.

• Tysabri PML Risk-Minimization Strategies Working, Study Finds

  September 16, 2019

  Martha Garcia

  Tysabri PML rates are on the decline after preventative guidelines went into effect, according to a new study.

• Commonly Used Drugs Linked To Four Serious Adverse Side Effects: ISMP Report

  October 2, 2018

  Irvin Jackson

  A number of drugs, including Abilify, Lipitor and Zoloft, were linked to several uncommon, potentially deadly drug side effects in 2017, according to a new report.

• Tysabri PML Infection Risk Increases With Long-Term Use: Study

  October 17, 2017

  Irvin Jackson

  A new study into the side effects of Tysabri indicate that the risk of a deadly brain infection increases the longer patients take the drug, and based on whether they've taken other immune system inhibitors in the past.

• Tysabri Brain Infection Side Effects Could Be Mitigated By Early Detection Through MRIs: Study

  January 19, 2017

  Irvin Jackson

  The findings of a new study suggest that the use of MRIs and other means of early detection could result in better outcomes in Tysabri patients who develop a potentially deadly form of brain infection associated with the MS drug.

• Tysabri Lawsuit Claims Manufacturer Delayed PML Brain Test To Maximize Profits

  June 16, 2016

  Irvin Jackson

  A lawsuit against the makers of Tysabri accuses them of sitting on a test for years that could have helped predict who was in danger of a potentially deadly brain infection associated with the drug.

• Tecfidera Brain Infection Results in FDA Warning Label Update

  November 26, 2014

  Irvin Jackson

  The FDA is requiring a new label warning detailing the death of a patient due to brain infection for the MS drug Tecfidera.

• Tecfidera Linked to Case of PML Brain Infection

  October 23, 2014

  Irvin Jackson

  The Biogen MS drug Tecfidera has been linked to the death of a patient due to a rare brain infection.

• Jakafi Risks Require Monitoring of Dose During First Three Months: Study

  December 30, 2013

  Irvin Jackson

  Doctors should closely monitor Jakafi patients for the first three months for signs of anemia, according to a new study.